Vaxcyte (PCVX) EPS (Weighted Average and Diluted) (2020 - 2026)
Vaxcyte (PCVX) reported EPS (Weighted Average and Diluted) of -$2.3 for Q1 2026, down 121.15% year-over-year from $10.87 in Q1 2025, and down 27.78% quarter-over-quarter from -$1.8 in Q4 2025.
Vaxcyte (PCVX) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$2.3 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$2.3, down 121.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.88 (down 72.43% YoY), and the FY2025 annual result was -$5.63, down 48.16% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$2.3 in Q1 2026 per PCVX's latest filing, from -$1.8 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.68 in Q1 2022 and troughed at -$2.3 in Q1 2026.
- A 5-year average of -$1.13 and a median of -$1.02 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2026: EPS (Weighted Average and Diluted) jumped 43.96% in 2024, then tumbled 121.15% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.02 in 2022, then sank by 78.43% to -$1.82 in 2023, then jumped by 43.96% to -$1.02 in 2024, then sank by 76.47% to -$1.8 in 2025, then retreated by 27.78% to -$2.3 in 2026.
- Business Quant data shows PCVX's EPS (Weighted Average and Diluted) at -$2.3 in Q1 2026, -$1.8 in Q4 2025, and -$1.56 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | -2.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.30 |
| Dec 31, 2025 | -1.80 |
| Sep 30, 2025 | -1.56 |
| Jun 30, 2025 | -1.22 |
| Mar 31, 2025 | -1.04 |
| Dec 31, 2024 | -1.02 |
| Sep 30, 2024 | -0.83 |
| Jun 30, 2024 | -1.10 |
| Mar 31, 2024 | -0.85 |
| Dec 31, 2023 | -1.82 |
| Sep 30, 2023 | -0.91 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.70 |
| Dec 31, 2022 | -1.02 |
| Sep 30, 2022 | -0.93 |
| Jun 30, 2022 | -0.80 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.51 |
| Jun 30, 2021 | -0.46 |